InsidersTradesSigma
Alzinova AB Stock: price and management transactions · Finland · FIN-FSA
Follow the Alzinova AB stock price and the full management transaction log of the company, a listed equity based in Finland. Shares are listed on FI FI, under the supervision of FIN-FSA. Operating in the Health Care sector, Alzinova AB has published 21 reports. Market capitalisation: €100.3m. The latest transaction was disclosed on 26 June 2026 (Purchase). Among the most active insiders: Sebastian Hansson. Every trade is free.
21
Insider Decl.
0
Thresholds
€317,473
12 ops.
Buy Volume
€34,283
2 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Alzinova AB Strong Buy (bullish), based on 2 analysts. Average price target: SEK 2.05.
41Σ signal
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 26 June 2026
Declarations21 total
90,000 shares@ SEK 0.52880.0040% mcap41.5% of flowAktieFI:csv-60e419fb0e52fd0e0695
Ideal exit: 21 Mar 2027 (T+270)
110,000 shares@ SEK 0.320.0047% mcap53.3% of flowAktieFI:csv-c3d84feb209f69745cd3
110,000 shares0TeckningsoptionFI:csv-13ce50cb6f1f7d66500a
9,375,000 shares@ SEK 0.020.024% mcap3.2% of flowTeckningsoptionFI:csv-24a536224aa4b53631cf
9,375,000 shares@ SEK 0.020.025% mcap3.3% of flowTeckningsoptionFI:A003Z720-1
29,316 shares0TeckningsoptionFI:csv-db64f03edd87208e2e8e
29,316 shares@ SEK 0.320.0012% mcap10.4% of flowAktieFI:csv-f65dd2d5e3d3af73ff47
78,386 shares0TeckningsoptionFI:csv-f6477a1808fd6006b287
78,386 shares@ SEK 0.320.0032% mcap27.9% of flowAktieFI:csv-e8df58adc826e8af8a14
41,666 shares@ SEK 0.120.0006% mcap5.6% of flowTeckningsoptionFI:csv-fd2ed5f27c0b391d457d
Ideal exit: 21 Feb 2027 (T+270)
49,025 shares@ SEK 0.120.0008% mcap100.0% of flowTeckningsoptionFI:csv-4cdedaeef8c8cca7c746
Ideal exit: 19 Feb 2027 (T+270)
50,000 shares@ SEK 0.1150.0007% mcap18.8% of flowTeckningsoptionFI:csv-02b56321a8b85ccde0f1
Ideal exit: 20 Feb 2027 (T+270)
20,000 shares@ SEK 0.46450.0012% mcap10.3% of flowAktieFI:csv-56ec4afbd3f8beecec17
Ideal exit: 19 Feb 2027 (T+270)
23,057 shares@ SEK 0.46450.0014% mcap11.9% of flowAktieFI:csv-dff153721929d1a1d791
Ideal exit: 19 Feb 2027 (T+270)
50,000 shares@ SEK 0.500.0032% mcap81.2% of flowAktieFI:csv-0a6f91ab5b92b78ffe19
Ideal exit: 15 Feb 2027 (T+270)
1,345,000 shares@ €0.22270.44% mcap58.8% of flowBTU (betald tecknad unit)FI:A003X091-1
Ideal exit: 8 Dec 2026 (T+270)
1,475,000 shares@ €0.14250.31% mcap41.2% of flowBTA (betald tecknad aktie)FI:A003O761-1
25,328 shares@ €0.1840.0068% mcap100.0% of flowBTA (betald tecknad aktie)FI:A003O073-1
Ideal exit: 31 Jan 2026 (T+270)
3,342 shares@ €0.1840.0009% mcap100.0% of flowBTA (betald tecknad aktie)FI:A003O065-1
Ideal exit: 31 Jan 2026 (T+270)
●
Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutives
6,646 shares@ €0.1840.0018% mcap43.8% of flowBTA (betald tecknad aktie)FI:A003O017-1
Ideal exit: 31 Jan 2026 (T+270)
●
Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutives
8,533 shares@ €0.1840.0023% mcap56.2% of flowBTA (betald tecknad aktie)FI:A003O015-1
Ideal exit: 31 Jan 2026 (T+270)
21 of 21 declarations
About Alzinova AB
Alzinova AB is a Swedish biopharmaceutical company focused on developing treatments for Alzheimer's disease. It is listed on the Stockholm Stock Exchange (XSTO).